The polymerizable liquid crystal compound has reverse wavelength dispersion or low wavelength dispersion and has high solubility in various solvents. The polymerizable liquid crystal compound provides an optically anisotropic body having high adhesiveness to substrates (or alignment films), by adding the polymerizable liquid crystal compound to a polymerizable composition and polymerizing the polymerizable composition using ultraviolet light. The invention provides a polymerizable composition containing the polymerizable liquid crystal compound having reverse wavelength dispersion or low wavelength dispersion, a polymer obtained by polymerizing the polymerizable composition, and an optically anisotropic body using the polymer. The present invention provides a polymerizable low wavelength dispersion or polymerizable reverse wavelength dispersion compound having in the molecule a partial structure represented by the general formula (AO-1); and also provides a composition containing the compound, a polymer obtained by polymerizing the composition, and an optically anisotropic body and the like using the polymer. ##STR00001##

The polymerizable liquid crystal compound has reverse wavelength dispersion or low wavelength dispersion and has high solubility in various solvents. The polymerizable liquid crystal compound provides an optically anisotropic body having high adhesiveness to substrates (or alignment films), by adding the polymerizable liquid crystal compound to a polymerizable composition and polymerizing the polymerizable composition using ultraviolet light. The invention provides a polymerizable composition containing the polymerizable liquid crystal compound having reverse wavelength dispersion or low wavelength dispersion, a polymer obtained by polymerizing the polymerizable composition, and an optically anisotropic body using the polymer. The present invention provides a polymerizable low wavelength dispersion or polymerizable reverse wavelength dispersion compound having in the molecule a partial structure represented by the general formula (AO-1); and also provides a composition containing the compound, a polymer obtained by polymerizing the composition, and an optically anisotropic body and the like using the polymer. ##STR00001##

The present invention relates to compound of Formula (I)

##STR00001##

containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor.

The present invention relates to compound of Formula (I)

##STR00001##

containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor.

The present invention relates to compound of Formula (I) containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor. ##STR00001##

The present invention relates to compound of Formula (I) containing carbon-carbon linker, a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a pharmaceutically acceptable solvate, a prodrug, a polymorph, N-oxide, S-oxide, or a carboxylic acid isostere thereof; processes for their preparation; pharmaceutical compositions comprising said compounds; and their use for the treatment of the diseases or disorders mediated by GPR120 receptor. ##STR00001##

A flow battery includes a first liquid containing a first electrode mediator dissolved therein, a first electrode immersed in the first liquid, a first active material immersed in the first liquid, and a first circulation mechanism that circulates the first liquid between the first electrode and the first active material, wherein the first electrode mediator includes a tetrathiafulvalene derivative, and the tetrathiafulvalene derivative has a chain-forming substituent at positions 4,4 and 5,5 of a tetrathiafulvalene skeleton thereof.

The present disclosure relates to methods and intermediates useful for preparing a compound of formula I:

##STR00001##

or a co-crystal, solvate, salt or combination thereof.

The present disclosure relates to methods and intermediates useful for preparing a compound of formula I:

##STR00001##

or a co-crystal, solvate, salt or combination thereof.

According to the present invention, a lens adhesive including a compound represented by General Formula 1 is provided.

Pol.sub.1-Sp.sub.1-L.sub.1-Ar-L.sub.2-Sp.sub.2-Pol.sub.2(General Formula 1)

In the formula, Ar is an aromatic ring group represented by General Formula 2-2 and the like.

##STR00001##

In the formula, Z.sub.1 and Z.sub.2 each represent a hydrogen atom, a methyl group, and the like; A.sub.1 and A.sub.2 each represent S and the like; X represents C(Rz).sub.2 and the like (where Rz is a substituent, and two Rz's may form a ring); L.sub.1 and L.sub.2 each represent a single bond, O, OC(O), OC(O)O, OC(O)NH, and the like; Sp.sub.1 and Sp.sub.2 each represent a single bond or a linking group such as a linear alkylene group; Pol.sub.1 and Pol.sub.2 each represent a hydrogen atom or a polymerizable group; and a compound represented by General Formula 1 has at least one polymerizable group. Using the lens adhesive, it is possible to provide a cemented lens that is unlikely to deteriorate due to light, and an imaging module having high durability.